Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 189
Severity: 8192
Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated
Filename: frontend/article.php
Line Number: 189
Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 190
Severity: 8192
Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated
Filename: frontend/article.php
Line Number: 190
Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 213
Severity: 8192
Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated
Filename: frontend/article.php
Line Number: 213
Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 214
Severity: 8192
Message: substr(): Passing null to parameter #1 ($string) of type string is deprecated
Filename: frontend/article.php
Line Number: 214
We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Severity: Warning
Message: Undefined array key "articleIDUniqueCode"
Filename: frontend/article.php
Line Number: 424
Ashokrao Mane College of pharmacy, Peth vadgaon, affiliated to Shivaji University 416112, Maharashtra, India
Adherence to medication and personalized treatment constitute the cornerstones of effective chronic disease management, yet the realization of their intent remains challenged by patient-specific, therapeutic, and systemic barriers. Due to the advancing availability of big health data and computational techniques, AI has made its stride into the health scenario as a disruptive force. This review discusses a variety of AI-powered tools used to monitor and enhance medication adherence?smart pill bottles, ingestible sensors, wearables, mHealth apps, and predictive analytics?and their incorporation into real-time clinical decision-making. We further discuss AI's role in developing personalized treatment regimens based on genomic data, adaptive algorithms, and electronic health records (EHR). The ethics of these challenges, including data privacy, algorithmic bias, and accountability, are further elucidated, alongside issues of in-field implementation. Lastly, along with the topics mentioned earlier, the review talks about future ideas like explainable AI, federated learning, and closed-loop adherence systems, which could help make AI a key part of personalized, proactive, and fair healthcare.
Adherence to medication is a critical aspect of effective health-care delivery and chronic disease management. This category ranges from diabetes to other cardiovascular disorders to psychiatric disorders. Irrespective of this importance, adherence rates still remain worryingly high, with estimates stating that almost 50 percent of patients do not take their medications as prescribed. This is a serious challenge before the clinician and the healthcare system, resulting in increased morbidity, hospitalizations, and health-care costs. Now this has resonated with some kind of an abdominal shift towards the patient, and treatment plans are becoming dependent on the predominant patient characteristics of emphasis (genetic makeup, lifestyle, and comorbidities). Personalized medicine apparently seems to be improving the therapeutic outcome with minimal effect; however, its potentials remain largely unrealized in the daily clinical setting. Artificial intelligence is transforming health care with a growing fascination, designing intelligent systems capable of analyzing vast amounts of patient data to predict adherence behavior and thus recommend treatment strategies tailored to the individual. Preventing medication non-adherence and enhancing individualized care will now be tackled along these integrated care pathways via the application of artificial intelligence (AI)-smart pill bottles, digital adherence monitoring systems, mobile apps, and clinical decision support tools. [2,3] The paper looks at how AI is currently being used in individualized treatment planning and drug adherence. The technology used in these activities will be covered, as well as their drawbacks and difficulties, moral and legal issues, and potential directions for AI advancement in healthcare.
2. An Overview of Healthcare Artificial Intelligence
AI is the replication of human intelligence in robots that have been trained to think and behave like people. AI in the health sector refers to a group of technologies that analyze complicated medical data and support clinical decision-making, including machine learning, deep learning, natural language processing, computer vision, and expert systems.AI technologies have demonstrated promise across a range of healthcare applications, from diagnostic imaging to patient triage and treatment optimization.[6] Machine learning algorithms can process high-dimensional data to identify patterns, make predictions, and continuously improve through experience.[7] NLP allows AI systems to interpret unstructured clinical notes, while computer vision tools are used for image analysis in radiology, dermatology, and pathology.[8] The applicability of artificial intelligence in healthcare mainly bases itself on the existence of sizable datasets and sources like electronic health records (EHR), genomic sequences, and real-time data collected from wearable devices. [9] Through these datasets, dummies are developed to assist predictive models that help clinicians try to guess the patient's outcomes, for recommending treatments, and even detect early signs of disease or deterioration. [10] Generative AI and large language models, specifically the ones under the umbrella of GPT-based systems, have ushered in several great possibilities in communication between patients and systems, summarization of data within a clinic, and instruction that is personalized in ways unimaginable before [11]. They have also been very useful in assisting a patient with medication adherence and for personalized treatment within a particular area of individual traits [12]. Although most of these developments have been made in AI whose transformations give adhesion over all forms of patient safety, ethical implications, and developments with data quality, algorithmic bias, as well as other regulatory compliance and trust among clinicians. Medication Adherence: Challenges and Current Strategies [13] Medication adherence means whether patients take medications according to the advice of their healthcare providers-whether or not the drugs are taken at the right time and in the right dosages and frequency. Non-adherence is a common problem, more so in chronic diseases, associated with increased morbidity and mortality and costs to healthcare. The World Health Organization states that about 50% of patients with chronic conditions do not adhere to their treatment and consequently obtain suboptimal clinical outcomes and poorer quality of life [1]
Fig. No. 1 Role of AI in healthcare
Such a range of adversities are brought together as leading to an event of medication non-adherence. Among these are:
Even if valuable, all those tend to have very high demands on human resources and also cannot always be sustainable or individualized. This lack opens up an avenue for continuous individual support assisted by AI through solutions enabled by technology. [15,16]
3. The Future of AI in Healthcare
The future of medical AI appears bright because engineers expect to develop its uses in healthcare through increasing sophistication. AI-driven advances in healthcare will become more visible through three key innovations which consist of virtual health assistants, robotic-assisted surgeries, and AI-powered mental health support systems. These systems could provide personalized and timely support, potentially reducing the burden on mental health professionals and improving patient outcomes. Integrating AI with blockchain technology will enhance patient data protection and the security of confidential patient information. The management of medical records through blockchain technology is a tamper-proof decentralized system that protects and gives authorized staff members complete access to medical information. The future of healthcare stands transformed because AI possesses revolutionary capabilities beyond what people could have predicted. AI-driven healthcare benefits patients when ethical matters receive proper attention. AI algorithms achieve high standards, and organizations implement AI responsibly. [17]
4. AI-Related Tools for Monitoring and Enhancement of Medication Compliance
Medication non-adherence is a multifactorial problem with causes, which include forgetfulness, an inadequate treatment understanding, side effects, poor finances, and lack of need perception. Old-school methods such as patient education and counseling, reminders, pill organizers, and many similar approaches have proven inadequate over time. With the increasing possibilities of artificial intelligence (AI), a new, dynamic generation of smart tools is emerging that will provide real-time, personalized, and adaptive interventions to manage adherence. [18]
4.1 Smart Pill Bottles and Ingestible Sensors
A smart pill bottle is a type of smart medication container that uses sensors built into the container to sense the opening of the container and log the time and frequency of a medication intake event. Such devices could communicate with cellphone apps or cloud systems for reminders and alerts to be made available to patients and/or caregivers. Products like Adhere Tech and Medication Event Monitoring System (MEMS) are examples of such devices. And ingestible sensors (e.g. Proteus Digital Health) embedded within pills can transmit data post-ingestion to confirm actual consumption. This system integrates artificial intelligence in analyzing the study of ingestion patterns; it thus flags the inconsistencies or missed doses [18].
Akanksha Kukade*, Sayali kawade, Sonakshi lokare, Ankita kharage, Artificial Intelligence in Medication Adherence and Personalized Treatment Plans, Int. J. Sci. R. Tech., 2025, 2 (5), 29-40. https://doi.org/10.5281/zenodo.15315405
10.5281/zenodo.15315405